Mounting evidence had demonstrated that PODXL, overexpressed in pancreatic cancer, hepatocellular, breast cancer, esophageal cancer, colorectal cancer and so forth, was considered as a tumor promoter. This evidence concerns the gene PODXL and breast carcinoma.